Liposomal targeting of angiogenic vasculature.
Active targeting of angiogenic vasculature represents a promising therapeutic strategy to fight a variety of diseases. In particular, attention has been focused on inhibition of tumor growth. In this review, the recent progress in targeting liposomes to angiogenic endothelial cells is discussed.
Schiffelers
Raymond M
RM
Dept. Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, PO Box 80.082, 3508 TB, Utrecht, The Netherlands. R.M.Schiffelers@pharm.uu.nl
Fens
Marcel H A M
MH
Janssen
Adriënne P C A
AP
Molema
Grietje
G
Storm
Gert
G
D020533:Angiogenesis Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D000818:Animals; D004337:Drug Carriers; D006801:Humans; D008081:Liposomes; D009369:Neoplasms / Q000473:pathology; D009389:Neovascularization, Pathologic / Q000188:drug therapy* / Q000473:pathology
D020533:Angiogenesis Inhibitors; D004337:Drug Carriers; D008081:Liposomes